Franz Recker
Overview
Explore the profile of Franz Recker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
2894
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Remmers S, Bangma C, Godtman R, Carlsson S, Auvinen A, Tammela T, et al.
Eur Urol
. 2023 Apr;
84(5):503-509.
PMID: 37088597
Background: The European Association of Urology guidelines recommend a risk-based strategy for prostate cancer screening based on the first prostate-specific antigen (PSA) level and age. Objective: To analyze the impact...
2.
Wetterauer C, Federer-Gsponer J, Leboutte F, Mona R, Ebbing J, Rentsch C, et al.
Urol Int
. 2021 Aug;
106(1):83-89.
PMID: 34350895
Introduction: Active surveillance (AS) strategies were established to avoid overtreatment of low-risk prostate cancer (PCa) patients. Low tumor volume represents one indication criteria; however, applying this criterion after MRI-targeted prostate...
3.
Prause L, Manka L, Millan C, Lang E, Wyler S, Grobholz R, et al.
World J Urol
. 2019 Dec;
38(10):2485-2491.
PMID: 31865534
Objectives: To analyze the influence of aspirin (ASA) intake on PSA values and prostate cancer (PCa) development in a prospective screening study cohort. Methods: 4314 men from the Swiss section...
4.
Carlsson S, Mansson M, Moss S, Kwiatkowski M, Recker F, Tammela T, et al.
Eur Urol
. 2019 Apr;
75(6):1015-1022.
PMID: 30928162
Background: Differential treatment between trial arms has been suggested to bias prostate cancer (PC) mortality in the European Randomized Study of Screening for Prostate Cancer (ERSPC). Objective: To quantify the...
5.
Hugosson J, Roobol M, Mansson M, Tammela T, Zappa M, Nelen V, et al.
Eur Urol
. 2019 Mar;
76(1):43-51.
PMID: 30824296
Background: The European Randomized study of Screening for Prostate Cancer (ERSPC) has previously demonstrated that prostate-specific antigen (PSA) screening decreases prostate cancer (PCa) mortality. Objective: To determine whether PSA screening...
6.
Heijnsdijk E, Bangma C, Borras J, M de Carvalho T, Castells X, Eklund M, et al.
Int J Cancer
. 2017 Oct;
142(4):741-746.
PMID: 29023685
The European Randomised Study of Screening for Prostate Cancer (ERSPC) showed that Prostate-Specific Antigen (PSA) based screening results in a significant prostate cancer mortality reduction. Although there are concerns on...
7.
Briollais L, Ozcelik H, Xu J, Kwiatkowski M, Lalonde E, Sendorek D, et al.
J Natl Cancer Inst
. 2017 Apr;
109(4).
PMID: 28376164
Background: There is a need for markers that can specifically identify individuals at increased risk of harboring aggressive forms of prostate cancer (PCa). Methods: We surveyed the Kallikrein ( KLK...
8.
Randazzo M, Muller A, Carlsson S, Eberli D, Huber A, Grobholz R, et al.
BJU Int
. 2015 Sep;
117(4):576-83.
PMID: 26332304
Objective: To assess the value of a positive family history (FH) as a risk factor for prostate cancer incidence and grade among men undergoing organised prostate-specific antigen (PSA) screening in...
9.
Randazzo M, Beatrice J, Huber A, Grobholz R, Manka L, Recker F, et al.
Urol Int
. 2015 Jan;
94(3):330-6.
PMID: 25633871
Introduction: Very low-risk prostate cancer (PCa) is being increasingly managed by active surveillance (AS). Our aim was to assess the influence of the origin of diagnosis on PCa characteristics and...
10.
Randazzo M, Beatrice J, Huber A, Grobholz R, Manka L, Chun F, et al.
Int J Cancer
. 2015 Jan;
137(3):553-9.
PMID: 25565393
Recent studies indicate frequent early PSA retesting unrelated of men's baseline PSA, which increases the harms of early detection especially among men with low PSA. The current study investigates the...